AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
SCWorx shares surge 12.79% intraday after renewing healthcare partner agreement with 113% higher contract value.
ByAinvest
Thursday, Nov 13, 2025 10:05 am ET1min read
SCWorx Corp. (WORX) surged 12.79% intraday after being granted an 180-day extension by Nasdaq to meet the minimum bid price requirement. This regulatory relief addresses ongoing delisting risks, providing the company additional time to stabilize its stock price and comply with exchange standards. The extension, announced six days prior, likely alleviated investor concerns about potential delisting, sparking immediate intraday buying activity. Other recent news, such as a healthcare partnership renewal and CTO appointment, occurred earlier and may have contributed to gradual momentum but are less directly tied to the sharp intraday rally.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet